141 related articles for article (PubMed ID: 17912468)
1. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations.
Sousa H; Santos AM; Pinto D; Medeiros R
Int J Mol Med; 2007 Nov; 20(5):731-41. PubMed ID: 17912468
[TBL] [Abstract][Full Text] [Related]
2. Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?
Sousa H; Santos AM; Pinto D; Medeiros R
Acta Med Port; 2011; 24(1):127-34. PubMed ID: 21672450
[TBL] [Abstract][Full Text] [Related]
3. p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women.
Agorastos T; Lambropoulos AF; Constantinidis TC; Kotsis A; Bontis JN
Eur J Cancer Prev; 2000 Apr; 9(2):113-8. PubMed ID: 10830578
[TBL] [Abstract][Full Text] [Related]
4. Analysis of p53 codon 72 polymorphism and its association with human papillomavirus 16 and 18 E6 in Chinese cervical lesions.
Min-min H; Ming-rong X; Ze-yi C; Kai-xuan Y; Zhi-lin S
Int J Gynecol Cancer; 2006; 16(6):2004-8. PubMed ID: 17177838
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.
Katiyar S; Thelma BK; Murthy NS; Hedau S; Jain N; Gopalkrishna V; Husain SA; Das BC
Mol Cell Biochem; 2003 Oct; 252(1-2):117-24. PubMed ID: 14577584
[TBL] [Abstract][Full Text] [Related]
6. p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.
Zehbe I; Voglino G; Wilander E; Delius H; Marongiu A; Edler L; Klimek F; Andersson S; Tommasino M
Cancer Res; 2001 Jan; 61(2):608-11. PubMed ID: 11212257
[TBL] [Abstract][Full Text] [Related]
7. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
8. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia.
Koushik A; Ghosh A; Duarte-Franco E; Forest P; Voyer H; Matlashewski G; Coutlée F; Franco EL;
Cancer Detect Prev; 2005; 29(4):307-16. PubMed ID: 16122882
[TBL] [Abstract][Full Text] [Related]
9. p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women.
Baek WK; Cho JW; Suh SI; Suh MH; Shin DH; Cho CH; Lee TS; Cha SD
J Korean Med Sci; 2000 Feb; 15(1):65-7. PubMed ID: 10719811
[TBL] [Abstract][Full Text] [Related]
10. P53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation.
Makni H; Franco EL; Kaiano J; Villa LL; Labrecque S; Dudley R; Storey A; Matlashewski G
Int J Cancer; 2000 Aug; 87(4):528-33. PubMed ID: 10918193
[TBL] [Abstract][Full Text] [Related]
11. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
12. HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India.
Saranath D; Khan Z; Tandle AT; Dedhia P; Sharma B; Contractor R; Shrivastava S; Dinshaw K
Gynecol Oncol; 2002 Aug; 86(2):157-62. PubMed ID: 12144822
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism at codon 72 of p53, human papillomavirus, and cervical cancer in South India.
Pillai MR; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
J Cancer Res Clin Oncol; 2002 Nov; 128(11):627-31. PubMed ID: 12458344
[TBL] [Abstract][Full Text] [Related]
14. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis.
Zhou X; Gu Y; Zhang SL
Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080
[TBL] [Abstract][Full Text] [Related]
15. p53 Arg72Pro polymorphism, HPV status and initiation, progression, and development of cervical cancer: a systematic review and meta-analysis.
Habbous S; Pang V; Eng L; Xu W; Kurtz G; Liu FF; Mackay H; Amir E; Liu G
Clin Cancer Res; 2012 Dec; 18(23):6407-15. PubMed ID: 23065429
[TBL] [Abstract][Full Text] [Related]
16. Codon 72 polymorphism of p53 and HPV type 16 E6 variants as risk factors for patients with squamous epithelial lesion of the uterine cervix.
Burroni E; Bisanzi S; Sani C; Puliti D; Carozzi F
J Med Virol; 2013 Jan; 85(1):83-90. PubMed ID: 23124863
[TBL] [Abstract][Full Text] [Related]
17. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.
Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H
BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760
[TBL] [Abstract][Full Text] [Related]
18. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis.
van Duin M; Snijders PJ; Vossen MT; Klaassen E; Voorhorst F; Verheijen RH; Helmerhorst TJ; Meijer CJ; Walboomers JM
J Gen Virol; 2000 Feb; 81(Pt 2):317-25. PubMed ID: 10644829
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis.
Jee SH; Won SY; Yun JE; Lee JE; Park JS; Ji SS
Int J Gynaecol Obstet; 2004 Jun; 85(3):301-8. PubMed ID: 15145278
[TBL] [Abstract][Full Text] [Related]
20. Selected risk factors, human papillomavirus infection and the p53 codon 72 polymorphism in patients with squamous intraepithelial lesions in northeastern Thailand.
Settheetham-Ishida W; Yuenyao P; Tassaneeyakul W; Kanjanavirojkul N; Thawmor A; Kularbkaew C; Hahvajanawong C; Settheetham D; Wattanathorn J; Kashima T; Ishida T
Asian Pac J Cancer Prev; 2006; 7(1):113-8. PubMed ID: 16629527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]